What’s New for Dermatology Drugs in 2017-2018

The specialty of Medical Dermatology has been in a renaissance for the last decade or so because of the development of many new injectable drugs for some common complex diseases such as Psoriasis, Psoriatic Arthritis, and Atopic Dermatitis, but also for some lesser known entities which we will discuss later.

Continue reading

METHOTREXATE–Reincarnation of an Old Drug

Methotrexate (MTX) is by far the most popular oral agent used by dermatologists today for psoriasis and has been so for the last 40 years.  Its epitaph was nearly written after the more potent biologic immunomodulators such as Enbrel and Humira were predicted to render MTX obsolete.  Now it appears that … Continue reading

Psoriasis Treatments

Psoriasis is a heavy burden for both the physical and economic health of the nation, affecting about 7.5 million Americans.  The annual cost for treating psoriasis in the U.S. in 2008 was $11.25 billion.  The average cost per patient, estimated at $5500 per year, is much higher for more severe … Continue reading